Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach;Dave S. B. Hoon;Klaus Pantel.
Nature Reviews Cancer (2011)
A landscape of driver mutations in melanoma
Eran Hodis;Ian R. Watson;Ian R. Watson;Gregory V. Kryukov;Gregory V. Kryukov;Gregory V. Kryukov;Stefan T. Arold.
Genomic Classification of Cutaneous Melanoma
Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert.
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf.
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
Mark B. Faries;John F. Thompson;Alistair J. Cochran;Robert H. Andtbacka.
The New England Journal of Medicine (2017)
Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
Sota Asaga;Christine Kuo;Tung Nguyen;Marilou Terpenning.
Clinical Chemistry (2011)
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao.
Cancer Cell (2018)
Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA
Richard B. Lanman;Stefanie A. Mortimer;Oliver A. Zill;Dragan Sebisanovic.
PLOS ONE (2015)
Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay.
D. S. B. Hoon;Yuan Wang;P. S. Dale;A. J. Conrad.
Journal of Clinical Oncology (1995)
Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
Peter J. Bostick;Sunanda Chatterjee;Dorcas D. Chi;Kelly T. Huynh.
Journal of Clinical Oncology (1998)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: